* Eastwood is a global biopharmaceutical R&D company focused on new drug development and the creation of pharmaceutical and medical materials, classified under NAICS 325410 — Pharmaceutical and Medicine Manufacturing in its Canadian securities disclosures (SEDAR+). While we hold multiple multinational pharmaceutical approvals, this website introduces only our functional-substance product line, which can be ordered and cleared through customs without a prescription. For pharmaceutical inquiries, please contact our head office.
TSX:V – EBM
For Eastwood Bio-Medical Canada Inc.’s financial filings please visit www.sedar.com for official public records.
Please click here for our investment deck.